FI982009L - Propofolin mikropisaraformulaatioita - Google Patents

Propofolin mikropisaraformulaatioita Download PDF

Info

Publication number
FI982009L
FI982009L FI982009A FI982009A FI982009L FI 982009 L FI982009 L FI 982009L FI 982009 A FI982009 A FI 982009A FI 982009 A FI982009 A FI 982009A FI 982009 L FI982009 L FI 982009L
Authority
FI
Finland
Prior art keywords
propofol
formulations
microdroplet formulations
propofol microdroplet
microdroplet
Prior art date
Application number
FI982009A
Other languages
English (en)
Swedish (sv)
Other versions
FI982009A7 (fi
FI982009A0 (fi
Inventor
Duncan H Haynes
Original Assignee
Res Triangle Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24469788&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI982009(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Res Triangle Pharm Ltd filed Critical Res Triangle Pharm Ltd
Publication of FI982009A7 publication Critical patent/FI982009A7/fi
Publication of FI982009A0 publication Critical patent/FI982009A0/fi
Publication of FI982009L publication Critical patent/FI982009L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Motorcycle And Bicycle Frame (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fats And Perfumes (AREA)
FI982009A 1996-03-19 1997-03-17 Propofolin mikropisaraformulaatioita FI982009L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/616,511 US5637625A (en) 1996-03-19 1996-03-19 Propofol microdroplet formulations
PCT/US1997/004168 WO1997034588A1 (en) 1996-03-19 1997-03-17 Propofol microdroplet formulations

Publications (3)

Publication Number Publication Date
FI982009A7 FI982009A7 (fi) 1998-09-17
FI982009A0 FI982009A0 (fi) 1998-09-17
FI982009L true FI982009L (fi) 1998-09-17

Family

ID=24469788

Family Applications (1)

Application Number Title Priority Date Filing Date
FI982009A FI982009L (fi) 1996-03-19 1997-03-17 Propofolin mikropisaraformulaatioita

Country Status (19)

Country Link
US (1) US5637625A (fi)
EP (1) EP0796616B1 (fi)
JP (1) JP2000507244A (fi)
KR (1) KR100484516B1 (fi)
CN (1) CN1124845C (fi)
AT (1) ATE182074T1 (fi)
AU (1) AU719756B2 (fi)
BR (1) BR9708099B8 (fi)
CA (1) CA2249375C (fi)
DE (1) DE69700317T2 (fi)
DK (1) DK0796616T3 (fi)
ES (1) ES2135969T3 (fi)
FI (1) FI982009L (fi)
GR (1) GR3031414T3 (fi)
HU (1) HU225046B1 (fi)
NO (1) NO324498B1 (fi)
NZ (1) NZ331669A (fi)
RU (1) RU2186564C2 (fi)
WO (1) WO1997034588A1 (fi)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6749868B1 (en) 1993-02-22 2004-06-15 American Bioscience, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US20070116761A1 (en) * 1993-02-22 2007-05-24 Desai Neil P Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
CA2234957C (en) * 1995-10-17 2006-12-19 Inge B. Henriksen Insoluble drug delivery
US6465016B2 (en) * 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
US7255877B2 (en) * 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
CH692322A5 (it) * 1997-05-26 2002-05-15 Westy Ag Formulazione iniettabile limpida di Propofol.
ES2435944T3 (es) * 1997-06-27 2013-12-26 Abraxis Bioscience, Llc Nuevas formulaciones de agentes farmacológicos, métodos para su preparación y métodos para su uso
US6638621B2 (en) * 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
CO4810371A1 (es) 1998-02-10 1999-06-30 Gensia Sicor Inc Composicion de propofol que contiene sulfito
ATE241363T1 (de) * 1998-02-11 2003-06-15 Rtp Pharma Corp Ungesättigte fettsäure und steroide enthaltende kombinationspräparate zur behandlung von entzündungen
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
US6254853B1 (en) * 1998-05-08 2001-07-03 Vyrex Corporation Water soluble pro-drugs of propofol
EP1079808B1 (en) 1998-05-29 2004-02-11 Skyepharma Canada Inc. Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
US6204257B1 (en) 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
JP4198318B2 (ja) 1998-08-19 2008-12-17 ヤーゴテック アクチェンゲゼルシャフト プロポフォールの注射可能水性分散物
US6150423A (en) * 1998-10-15 2000-11-21 Phoenix Scientific, Inc. Propofol-based anesthetic and method of making same
US6140374A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
US7939105B2 (en) 1998-11-20 2011-05-10 Jagotec Ag Process for preparing a rapidly dispersing solid drug dosage form
CN1151782C (zh) * 1999-01-28 2004-06-02 迪内希·尚蒂拉尔·帕特尔 一种具有哺乳动物麻醉的诱导和保持以及镇静用途的药用注射液
US6177477B1 (en) * 1999-03-24 2001-01-23 American Home Products Corporation Propofol formulation containing TRIS
US6100302A (en) * 1999-04-05 2000-08-08 Baxter International Inc. Propofol formulation with enhanced microbial characteristics
GB2350297A (en) * 1999-05-27 2000-11-29 Abbott Lab Injectable halogenated anesthetic formulation in emulsion form
JP2003509453A (ja) * 1999-09-21 2003-03-11 アールティーピー・ファーマ・インコーポレーテッド 生物学的に活性な物質の、表面改質された粒状組成物
US6071933A (en) * 1999-12-03 2000-06-06 Diversified Medical Innovations, Inc. Homogeneous remifentanil-propofol blend for patient controlled anesthesia and process for its use
GB2359747B (en) * 2000-02-29 2002-04-24 Maelor Pharmaceuticals Ltd Anaesthetic formulations
JP5102423B2 (ja) 2000-04-20 2012-12-19 オバン・エナジー・リミテッド 改善された水不溶性薬剤粒子の処理
AU6689601A (en) 2000-06-16 2002-01-02 Rtp Pharma Inc Improved injectable dispersions of propofol
US6623765B1 (en) 2000-08-01 2003-09-23 University Of Florida, Research Foundation, Incorporated Microemulsion and micelle systems for solubilizing drugs
JP4969761B2 (ja) 2000-08-31 2012-07-04 オバン・エナジー・リミテッド 所望粒度を持つ固体基材の小粒子および第一材料の小粒状物を含む相乗作用性混合物を製造する方法
NZ525231A (en) * 2000-09-20 2004-08-27 Skyepharma Canada Inc Phospholipid stabilised feno-fibrate microparticles for pharmaceutical use
US8586094B2 (en) 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
US6534088B2 (en) * 2001-02-22 2003-03-18 Skyepharma Canada Inc. Fibrate-statin combinations with reduced fed-fasted effects
CA2451432A1 (en) 2001-06-23 2003-01-03 Lyotropic Therapeutics, Inc. Particles with improved solubilization capacity
US20030054042A1 (en) * 2001-09-14 2003-03-20 Elaine Liversidge Stabilization of chemical compounds using nanoparticulate formulations
EP1430017A2 (en) 2001-09-26 2004-06-23 Theravance, Inc. Substituted phenol compounds useful for anesthesia and sedation
AU2002337692B2 (en) * 2001-09-26 2007-09-13 Baxter International Inc. Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
KR20040080444A (ko) * 2001-12-28 2004-09-18 길포드 파마슈티컬스 인코포레이티드 수용성인 프로포폴 전구약물의 약학적 수성 제제
US20080220075A1 (en) * 2002-03-20 2008-09-11 Elan Pharma International Ltd. Nanoparticulate compositions of angiogenesis inhibitors
AU2003230691A1 (en) * 2002-03-20 2003-10-08 Elan Pharma International Ltd. Nanoparticulate compositions of angiogenesis inhibitors
US20050203068A1 (en) * 2002-04-08 2005-09-15 Peggy Wingard Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same
US20040220283A1 (en) * 2002-07-29 2004-11-04 Transform Pharmaceuticals, Inc. Aqueous 2,6-diisopropylphenol pharmaceutical compositions
US7550155B2 (en) * 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
CA2494297C (en) * 2002-07-29 2011-10-18 Transform Pharmaceuticals, Inc. Aqueous 2,6-diisopropylphenol pharmaceutical compositions
US20040171691A1 (en) * 2002-10-29 2004-09-02 Transform Pharmaceuticals, Inc. Propofol with cysteine
JPWO2004052354A1 (ja) * 2002-12-06 2006-04-06 株式会社大塚製薬工場 プロポフォール含有脂肪乳剤
US20040225022A1 (en) * 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
US7182948B2 (en) * 2003-08-04 2007-02-27 Ko Manufacturing, Inc. Topical veterinary compositions and methods for the treatment and prevention of infection
JP5032849B2 (ja) * 2004-01-14 2012-09-26 ギリアード サイエンシーズ， インコーポレイテッド 薬物送達に有用な脂質ベースの分散物
US7125954B2 (en) 2005-01-27 2006-10-24 General Electric Company Method for producing polyether polymers
MX2007015183A (es) * 2005-06-14 2008-02-19 Baxter Int Formulaciones farmaceuticas para minimizar las interacciones farmaco-farmaco.
US8034765B2 (en) * 2005-08-31 2011-10-11 Abraxis Bioscience, Llc Compositions and methods for preparation of poorly water soluble drugs with increased stability
BRPI0615265A8 (pt) 2005-08-31 2018-03-06 Abraxis Bioscience Llc composições compreendendo agentes farmacêuticos pouco hidrossoluíveis e agentes antimicrobianos
WO2007059515A2 (en) * 2005-11-15 2007-05-24 Baxter International, Inc. Compositions of lipoxygenase inhibitors
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) * 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
RU2535001C1 (ru) * 2013-07-11 2014-12-10 Общество с ограниченной ответственностью "ВИК-здоровье животных" Микроколлоидный раствор пропофола для анестезии
EP3302433A4 (en) * 2015-06-01 2019-01-23 Autotelic LLC THERAPEUTIC AGENT NANOPARTICLES COATED WITH PHOSPHOLIPID AND ASSOCIATED METHODS
US20160346219A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
WO2017218630A2 (en) * 2016-06-15 2017-12-21 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
CN114867467B (zh) * 2019-12-20 2025-06-20 费森尤斯卡比奥地利有限公司 用于产生水包油乳剂的方法
EP4056038A1 (en) * 2021-03-10 2022-09-14 Basf Se Microparticles containing active substances

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
US4798846A (en) * 1974-03-28 1989-01-17 Imperial Chemical Industries Plc Pharmaceutical compositions
US4725442A (en) * 1983-06-17 1988-02-16 Haynes Duncan H Microdroplets of water-insoluble drugs and injectable formulations containing same
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
CH669523A5 (fi) * 1986-06-25 1989-03-31 Mepha Ag
SU1569018A1 (ru) * 1987-07-07 1990-06-07 Ленинградский химико-фармацевтический институт Способ нанесени покрыти на таблетки
DE4132677C2 (de) * 1991-10-01 1995-08-24 Braun Melsungen Ag Flüchtige Inhalationsnarkotika enthaltende Liposomen, ihre Herstellung und Verwendung
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
US5496537A (en) * 1995-03-23 1996-03-05 Henry; Richard A. Propofol hydrofluorocarbon propellant formulations

Also Published As

Publication number Publication date
NO984370L (no) 1998-09-18
ATE182074T1 (de) 1999-07-15
KR20000064762A (ko) 2000-11-06
CN1218398A (zh) 1999-06-02
NO324498B1 (no) 2007-10-29
CN1124845C (zh) 2003-10-22
EP0796616A1 (en) 1997-09-24
BR9708099A (pt) 2000-01-04
DE69700317T2 (de) 1999-12-02
HU225046B1 (hu) 2006-05-29
GR3031414T3 (en) 2000-01-31
ES2135969T3 (es) 1999-11-01
RU2186564C2 (ru) 2002-08-10
HUP9902553A2 (hu) 2000-10-28
US5637625A (en) 1997-06-10
FI982009A7 (fi) 1998-09-17
HUP9902553A3 (en) 2001-04-28
FI982009A0 (fi) 1998-09-17
EP0796616B1 (en) 1999-07-14
DK0796616T3 (da) 1999-11-29
KR100484516B1 (ko) 2005-09-02
NO984370D0 (no) 1998-09-18
CA2249375A1 (en) 1997-09-25
BR9708099B1 (pt) 2010-02-23
BR9708099B8 (pt) 2014-04-29
NZ331669A (en) 2000-01-28
AU2329297A (en) 1997-10-10
JP2000507244A (ja) 2000-06-13
CA2249375C (en) 2002-06-18
DE69700317D1 (de) 1999-08-19
AU719756B2 (en) 2000-05-18
WO1997034588A1 (en) 1997-09-25

Similar Documents

Publication Publication Date Title
HUP9902553A3 (en) Propofol microdroplet formulations
DE69722930D1 (de) Pestizide zusammensetzungen
BR9710053A (pt) Composições pesticidas
ID17241A (id) Komposisi-komposisi pestisida
MA24473A1 (fr) Formulations
DE69723714D1 (de) Koaleszenzelement
ID22931A (id) Komposisi-komposisi herbisidal
ID25533A (id) Formulasi 2-metil-tieno-benzodiazepin
ID16251A (id) Komposisi-komposisi pembasmi kuman
ID17685A (id) Komposisi-komposisi deodoran
DK1298194T3 (da) Staniolholdige sammensætninger
ID18352A (id) Komposisi-komposisi farmasi
DE69708866D1 (de) Mikroverkapselte zusammensetzungen
ID17774A (id) Komposisi farmasi antitrombosis
DE69733072D1 (de) Farbschonende zusammensetzungen
DE69723704D1 (de) Pestizidzusammensetzungen
DE69719442D1 (de) Frisierschaum-Zusammensetzungen
ID25650A (id) Komposisi-komposisi sampo
ATE261133T1 (de) Lagerstabile hydrogele
NO991771D0 (no) Sprengstoff-formuleringer
PT941100E (pt) Composicoes farmaceuticas
DE69826706D1 (de) Wäscheweichmittelzusammensetzungen
DE69706214D1 (de) Photoresistzusammensetzung
DE69736678D1 (de) Dermatologische zusammensetzungen
ATE211884T1 (de) Halopropargyl-einschlussverbindungen

Legal Events

Date Code Title Description
MA Patent expired